Importantly, the PPT2 is the first reported spontaneously immortalized prostate cancer cell line established from a primary prostate tumor, which possesses profound stemness characteristics, including up-regulated stemness genes, high sphere-forming, clonogenic and tumorigenic capacities and high resistance to chemotherapeutic drugs. The gene discussed is PPT2; the disease is prostate carcinoma.